# Study on the Use of Sarilumab in Patients With COVID-19 Infection

> **NCT04386239** · EARLY_PHASE1 · WITHDRAWN · sponsor: **ASST Fatebenefratelli Sacco**

## Conditions studied

- COVID19

## Interventions

- **DRUG:** Sarilumab Prefilled Syringe

## Key facts

- **NCT ID:** NCT04386239
- **Lead sponsor:** ASST Fatebenefratelli Sacco
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-01-01
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Technical impasse from IRB
- **Last updated:** 2023-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04386239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04386239, "Study on the Use of Sarilumab in Patients With COVID-19 Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04386239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*